Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Soler

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Journal of Immunology Research|October 30, 2023
Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood NeutrophilsEugene R Bleecker, Reynold A Panettieri, Njira L Lugogo, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2023
Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics OutlookKlaus F Rabe, Stephen Rennard, Fernando J Martinez, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 20, 2021
Effect of Triple Therapy with Budesonide-Formoterol-Tiotropium Versus Placebo-Tiotropium on Sleep Quality in Patients with Chronic Obstructive Pulmonary DiseaseSamuel L Krachman, Maria Elena Vega, Daohai Yu, et al.
Frontiers in Cell and Developmental Biology|December 27, 2021
Developmental Disruption of <i>Erbb4</i> in <i>Pet1</i>+ Neurons Impairs Serotonergic Sub-System Connectivity and Memory FormationCandela Barettino, Álvaro Ballesteros-Gonzalez, Andrés Aylón, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 6, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthmaWilliam W Busse, Monica Kraft, Christian Domingo, et al.
Advances in Therapy|December 9, 2024
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global RegistryNjira L Lugogo, Xavier Soler, Yasuhiro Gon, et al.
American Journal of Respiratory and Critical Care Medicine|February 12, 2025
Current Smoker: A Clinical COPD Phenotype Affecting Disease Progression and Response to TherapyBartolome R Celli, Stephanie Christenson, Klaus F Rabe, et al.
ERJ Open Research|October 20, 2023
Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 26, 2023
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitizationJonathan Corren, Nicola A Hanania, William W Busse, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2024
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with AsthmaIan D Pavord, Lucia De Prado Gómez, Guy Brusselle, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Journal of Immunology Research|October 30, 2023
Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood NeutrophilsEugene R Bleecker, Reynold A Panettieri, Njira L Lugogo, et al.
American Journal of Respiratory and Critical Care Medicine|June 22, 2023
Targeting Type 2 Inflammation and Epithelial Alarmins in Chronic Obstructive Pulmonary Disease: A Biologics OutlookKlaus F Rabe, Stephen Rennard, Fernando J Martinez, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 20, 2021
Effect of Triple Therapy with Budesonide-Formoterol-Tiotropium Versus Placebo-Tiotropium on Sleep Quality in Patients with Chronic Obstructive Pulmonary DiseaseSamuel L Krachman, Maria Elena Vega, Daohai Yu, et al.
Frontiers in Cell and Developmental Biology|December 27, 2021
Developmental Disruption of <i>Erbb4</i> in <i>Pet1</i>+ Neurons Impairs Serotonergic Sub-System Connectivity and Memory FormationCandela Barettino, Álvaro Ballesteros-Gonzalez, Andrés Aylón, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 6, 2025
Impact of asthma age of onset or duration on efficacy of dupilumab in moderate-to-severe type 2 asthmaWilliam W Busse, Monica Kraft, Christian Domingo, et al.
Advances in Therapy|December 9, 2024
Baseline Characteristics of Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global RegistryNjira L Lugogo, Xavier Soler, Yasuhiro Gon, et al.
American Journal of Respiratory and Critical Care Medicine|February 12, 2025
Current Smoker: A Clinical COPD Phenotype Affecting Disease Progression and Response to TherapyBartolome R Celli, Stephanie Christenson, Klaus F Rabe, et al.
ERJ Open Research|October 20, 2023
Impact of exacerbation history on long-term efficacy of dupilumab in patients with asthmaJonathan Corren, Constance H Katelaris, Mario Castro, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 26, 2023
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma with fungal sensitizationJonathan Corren, Nicola A Hanania, William W Busse, et al.
American Journal of Respiratory and Critical Care Medicine|February 8, 2024
Biomarkers Associated with Lung Function Decline and Dupilumab Response in Patients with AsthmaIan D Pavord, Lucia De Prado Gómez, Guy Brusselle, et al.
Pageof 8